http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007243187-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8f6f81f8f961ef904cd837a5f7f46fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d0f37c4af9f65e41bad5cb4618910d5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2004-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57fd1d223eaecc4f5170ca0a50cbaf96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7aad10113e0cd2c5115747bb090be5d
publicationDate 2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007243187-A1
titleOfInvention Methods and Materials for Treating Autoimmune Diseases and Conditions
abstract Disclosed are methods for treating an autoimmune disease or condition in a subject. The methods include administering to the subject a compound which inhibits the subject's classical complement pathway. Also disclosed are methods for suppressing hyperacute graft rejection in a subject. The methods include administering to the subject a compound which inhibits the subject's classical complement pathway. Compositions which include a specific inhibitor of C1q and a pharmaceutically acceptable excipient are also described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010135992-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009028850-A1
priorityDate 2003-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6180370-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019326-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6492403-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977076-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511121-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129157877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17904358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128757924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8434

Total number of triples: 45.